Diabetes on the Net is intended for healthcare professionals
This promotional webinar series and respective materials have been developed, organised and funded by Novo Nordisk.
For healthcare professionals only.
Promotional information on insulin degludec (Tresiba®) will be discussed in this webinar. Click here to view prescribing information and adverse event reporting information for insulin degludec (Tresiba®). Insulin degludec (Tresiba®) is indicated for the treatment of diabetes mellitus in adults, adolescents and children from the age of 1 year.